Kexin Xu1,1, Zhenhua J. Wu2,2, Anna C. Groner1,1, Housheng Hansen He2,1, Changmeng Cai3, Rosina T. Lis4,1,5, Xiaoqiu Wu4,1, Edward C. Stack4,1,5, Massimo Loda4,1,5,6, Tao Liu2,2, Han Xu2,2, Laura Cato1,1, James E. Thornton7,8, Richard I. Gregory7,8, Colm Morrissey9, Robert L. Vessella9,10, Rodolfo Montironi11, Cristina Magi‐Galluzzi12, Philip W. Kantoff1, Steven P. Balk3, X. Shirley Liu2,2, Myles Brown1,1
1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
2Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115, USA
3Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
4Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
5Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
6Division of Cancer Studies, King’s College London, London SE1 8UB, UK.
7Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA
8Stem Cell Program, Children's Hospital, Boston, MA 02115, USA
9Department of Urology, University of Washington Medical Center, Seattle, WA 98195, USA.
10Puget Sound VA Health Care System, Seattle, WA 98108, USA.
11Section of Pathological Anatomy, Polytechnic University of Marche Region, United Hospitals, 60126 Torrette, Ancona, Italy.
12Pathology and Laboratory Medicine Institute, Glickman Urological and Kidney Institute, Department of Cancer Biology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
